|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 65,100 VND | 0.00% |
|
+0.93% | +15.02% |
Imexpharm Corporation reported earnings results for the fourth quarter ended December 31, 2022. For the fourth quarter, the company reported revenue was VND 557,160.11 million compared to VND 396,516.72 million a year ago. Net income was VND 78,961.49 million compared to VND 66,595.89 million a year ago.
Basic earnings per share from continuing operations was VND 1,263.8095 compared to VND 877.1429 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| +15.02% | 180M | |
| +26.08% | 662B | |
| +21.85% | 546B | |
| -4.77% | 359B | |
| +16.97% | 323B | |
| +5.69% | 290B | |
| +13.68% | 234B | |
| +3.65% | 198B | |
| -11.12% | 194B | |
| +8.08% | 167B |
IMEXPHARM CORPORATION 
